ArticleScience progress
The mediating effects of the triglyceride-glucose index in the association between circadian syndrome and breast cancer: Evidence based on NHANES and TCGA databases.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveBreast cancer (BC) is a major global health issue for women. Although insulin resistance (IR) and circadian disruption are both associated with BC, their interaction remains unclear. This study examined the association between circadian syndrome (CircS) and BC, and explored the mediating role of the triglyceride-glucose (TyG) index and related molecular mechanisms.MethodsThis cross-sectional study analyzed 5,498 women from the NHANES 2005-2014. Multivariate logistic regression assessed the association between CircS and BC, with mediation analysis to evaluate TyG's indirect effect. Bioinformatics validation used TCGA-BRCA data, including differential expression of TyG and circadian rhythm-related gene sets, survival analysis, and pathway enrichment.ResultsAmong 5,498 participants, 158 had BC. After adjusting for sociodemographic, lifestyle, and cardiovascular factors, CircS was significantly associated with higher BC risk (OR = 2.07, 95% CI: 1.12-3.83). Each one-unit increase in the TyG index was also linked to increased BC risk (OR = 1.64, 95% CI: 1.20-2.23). Mediation analysis showed the TyG index mediated 10.84% of CircS's effect on BC (Indirect Effect: 0.0042, 95% CI: 0.0011-0.0103). Bioinformatics analysis identified dysregulated prognostic circadian rhythm DEGs and insulin receptor DEGs in tumors, and their expression correlated with overall survival. These genes were co-enriched in oncogenic pathways such as lipid metabolism and MAPK signaling.ConclusionsThis nationally representative study indicates that CircS is strongly associated with a higher prevalence of BC, with IR-measured by the TyG index-partially mediating this association. Molecular evidence shows that circadian and metabolic disruptions converge on key signaling pathways, suggesting a synergistic role in BC development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.